RecruitingNot ApplicableNCT05309876
Secondary Prevention With the Lifestyle Tool
Secondary Prevention of Cardiovascular Disease With the Lifestyle Tool
Sponsor
Region Skane
Enrollment
11,000 participants
Start Date
Apr 6, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
In this study participants will be randomized to use a digital lifestyle tool over three years or to a control group without access to the tool. The investigators will prospectively follow the incidence of major cardiovascular events in patients who have previously suffered from a myocardial infarction in those using the tool regularly and those in the control group.
Eligibility
Min Age: 35 YearsMax Age: 80 Years
Inclusion Criteria3
- age 35 to 80 years
- myocardial infarction within one year prior to enrolment
- access to computer or mobile phone.
Exclusion Criteria1
- conditions or treatments that in the judgement of the Investigator could affect the study evaluation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALLifestyle tool
Regular use of the digital Lifestyle tool
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05309876
Related Trials
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT061870121 location
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731152 locations
SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation
NCT068867891 location
Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
NCT058814471 location